돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 11859생성일: 2026년 10월 25일

Tryptamine → Nalpha-Fmoc-Ndelta-Cbz-L-ornithine 2-(3-indolyl)ethylamide

https://huagongshe.com/reaction/11859

반응식

참여 물질

역할이름HCID투입량
반응물TryptamineHCID 1150—
반응물1-HydroxybenzotriazoleHCID 75771—
반응물1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
반응물Fmoc-orn(Z)-OHHCID 14999635—
용매DimethylformamideHCID 6228—
생성물Nalpha-Fmoc-Ndelta-Cbz-L-ornithine 2-(3-indolyl)ethylamideHCID 86592267—

반응 단계

Commercially available Nα-Fmoc-Nδ-Cbz-L-ornithine (528.0 mg) was dissolved in DMF (10.6 ml), and HOBt (235 mg), WSCI hydrochloride (334 mg), and tryptamine (0.165 ml) were added to the solution. The mixture was stirred for 16 hours at room temperature. After the reaction, the solvent was removed by distillation. The residue was dissolved in chloroform and extracted with 1 mol/l aqueous solution of hydrochloric acid. The organic layer was washed with a saturated aqueous solution of sodium bicarbonate. The solvent was removed by distillation and the residue was purified by silica gel column chromatography (50 g, chloroform/ethyl acetate=1/1) to obtain the title compound (690 mg) as a white solid.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07098215B2
출처 데이터셋uspto-grants-2006_08
ORD IDord-65c497fe5d834364a584b9d25bebadc4
출처 메모uspto-grants-2006_08